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Abstract:  
Rationale. Men have poorer health status and are less likely to attend health screening 
compared to women.  
Objective. This systematic review presents current evidence on the barriers and facilitators to 
engaging men in health screening.  
Methods.  We included qualitative, quantitative and mixed-method studies identified through 
five electronic databases, contact with experts and reference mining. Two researchers 
selected and appraised the studies independently. Data extraction and synthesis were 
FRQGXFWHGXVLQJWKHµEHVWILW¶IUDPHZRUNV\QWKHVLVPHWKRG 
Results. 53 qualitative, 44 quantitative and 6 mixed-method studies were included. Factors 
influencing health screening uptake in men can be categorized into five domains: individual, 
social, health system, healthcare professional and screening procedure. The most commonly 
reported barriers are fear of getting the disease and low risk perception; for facilitators, they 
are perceived risk and benefits of screening. Male-dominant barriers include heterosexual -
self-presentation, avoidance of femininity and lack of time. The partner's role is the most 
common male-dominant facilitator to screening.  
Conclusions. This systematic review provides a comprehensive overview of barriers and 
facilitators to health screening in men including the male-dominant factors. The findings are 
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particularly useful for clinicians, researchers and policy makers who are developing 
interventions and policies to increase screening uptake in men.  
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quantitative 
 
Highlights:  
x Health screening uptake in men is influenced by widely varying factors. 
x Commonly reported barriers include fear of getting the disease and low risk perception. 
x Commonly reported facilitators include perceived at risk and benefits of screening.  
x Male-dominant barriers include heterosexual self-presentation and to avoid femininity. 
x Partner's role is the most commonly reported male-dominant facilitator to screening. 
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Introduction 
Globally, men do not live as long as women (Barford et al., 2006; WHO, 2011) and 
have higher mortality and morbidity rates across most of the diseases (AIHW, 2013; Bilsker 
et al., 2010; EC, 2011; Ng et al., 2014; White et al., 2011a). Possible explanations include 
PHQ¶VSRRUKHDOWKVHHNLQJEHKDYLRUODFNRIKHDOWKNQRZOHGJHULVNWDNLQJEHKDYLRUDVZHOODV
their reluctance to engage in health promotion activities (Addis & Mahalik, 2003; Byrnes et 
al., 1999; Courtenay, 2003).  
9DULRXVVWUDWHJLHVFDQEHXVHGWRLPSURYHWKHVWDWXVRIPHQ¶VKHDOWKSDUWLFXODUO\
health screening. Through health screening, one can identify a disease at the early stage 
allowing intervention before the disease worsens. For instance, a study on the impact of 
cardiovascular disease (CVD) screening reported that screening attenders have lower CVD 
mortality rate, all-cause mortality rate, healthcare utilization and cost compared to non-
attenders (Lee et al., 2015). A one percent reduction of cardiovascular events through a 
preventive program across England and Wales has the potential to save at least £30 million of 
health services cost per year (Barton et al., 2011). Similarly, screening for colorectal cancer 
using faecal occult blood test (FOBT) was reported to decrease the relative risk of colorectal 
cancer death by 15-20%, save 3.8-8.29 quality adjusted life days per person and £1,890-
£2,576 of healthcare cost per life year (Hewitson et al., 2007; Tappenden et al., 2004). 
In spite of all the benefits of screening, screening uptake is low, particularly in men. 
The uptake rates of guaiac-based faecal occult blood (gFOB) test in the UK Bowel Cancer 
Screening Programme were lower in men across all three rounds of the biennial invitation 
(first round: men 53.3% vs women 61.3%; second round: men 58.0% vs women 63.7%; third 
round: men 64.1% vs women 68.2%) (Lo et al., 2015). Another study on screening uptake in 
Ontario showed a similar pattern where the uptake of screening was lower in men for 
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colorectal cancer (men 55.1% vs women 61.6%), diabetes (men 61.4% vs women 72.9%) and 
cholesterol (men 70.3% vs women 82.4%) (Borkhoff et al., 2013). A narrative scoping 
review on socio-determinants of screening uptake cites nine studies that indicated men were 
less likely to engage health screening compared to women, particularly men who are less 
educated, unemployed and from low socio-economic status (Dryden et al., 2012). However, 
this review did not provide reasons for the low screening uptake in men.  
For a screening intervention to be effective, it is important that it is tailored to the 
characteristics of the population, such as using a gendered approach. Masculinity attributes 
like avoidance of femininity, toughness and risk taking have been used to explain the 
difference in health screening behavior between men and women (Connell, 1987, 1995). The 
Madrid Statement, released by the World Health Organization (WHO) in 2001, clearly states 
that health policies must recognize that men and women have different needs, obstacles and 
opportunities in order to attain the highest standard of health (WHO, 2001 ). Experts have 
argued the importance of considering gender when developing interventions, programs and 
policies in recognition that men and women behave differently (Baker et al., 2014; Banks, 
2004; Weller & Campbell, 2009; White et al., 2011b).  
This systematic review thus aims to review the existing evidence on the barriers and 
facilitators to engaging men in health screening. We sought to identify the most commonly 
reported barriers and facilitators to health screening along with those barriers and facilitators 
that are particularly prominent in a male population (male-dominant). We hope that 
identification of these factors will help in the development of effective interventions to 
overcome these barriers and improve screening uptake in men. However, this review did not 
include studies focusing on certain male populations, such as gay and aboriginal men, as 
there are unique factors that influence their health screening behavior which deserve separate 
reviews.  
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Methods 
Eligibility Criteria 
We included qualitative, quantitative and mixed-PHWKRGVWXGLHVWKDWLGHQWLILHGPHQ¶V
barriers or facilitators in engaging with health screening. For inclusion, a study must clearly 
differentiate the barriers or facilitators between men and women. Informants could include 
men or women patients or healthcare professionals as long as the barriers or facilitators 
discussed are those for male patients. Studies included in the review investigate men who 
have attended for screening, as well as non-attenders. Participants could be derived from any 
age group and they must be asymptomatic of the disease for the screening planned in each 
study. We excluded studies that focused on men who were gene carriers, prisoners, disabled, 
drug users, in military service, homeless, immigrants, refugees as well as aboriginal and gay 
men. These groups of men face additional barriers when seeking healthcare and they deserve 
separate reviews.  
We included all types of screening recommended by the United States Preventive 
Services Task Force (USPSTF) as well as male-specific diseases like prostate and testicular 
cancer screening (United States Preventive Services Task Force, 2016). We included studies 
on prostate cancer screening conducted before 2012 as USPSTF recommended against 
prostate cancer screening after that. Studies of barriers or facilitators of screening carried out 
as a part of a screening program were also included in this review. We excluded genetic tests 
for prostate cancer and studies that focus on screening at the emergency department. Studies 
that used an intervention to increase screening uptake, looked solely at socio-demographic 
determinants or focused on physiFLDQV¶VFUHHQLQJSUDFWLFHVZHUHDOVRH[FOXGHGIURPWKLV
review.  
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Information Sources and Search 
We searched five key databases (PubMed, Embase, CINAHL via EBSCOHost, 
PsycINFO via OvidSP and Web of Science) up to 23 October 2014 to identify relevant 
articles. We combined three main concepts (men, screening, barrier/facilitator) and a 
methodological filter (qualitative/survey) using keywords and subject headings from 
respective databases in the search. The search strategy can be found in Appendix A. We only 
included articles published in English. Apart from database searching, we also sourced 
UHOHYDQWDUWLFOHVIURPPHQ¶VKHDOWKH[SHUWVDQGIROORZHGXSUHIHUHQFHVLQHOLJLEOHDUWLFOHV 
 
Study Selection and Appraisal  
Two researchers performed all phases of study sifting and selection independently, 
including screening of titles, abstracts and full-texts. In cases of doubt, the researchers were 
encouraged to be inclusive. Any discrepancies were resolved through discussion and 
consensus. All the included studies were appraised using the Mixed-Method Appraisal Tool 
(MMAT) which allows appraisal of the validity, reliability and generalizability of the 
quantitative, qualitative and mixed-method studies (Appendix B) (Pluye et al., 2011). It can 
also be used quickly and reliably (Pace et al., 2012). For mixed-method studies, both 
qualitative and quantitative components of the studies were appraised. The appraisal was 
conducted to report the quality of the studies and not used as a threshold for selecting studies 
for inclusion.  
 
Data Extraction and Synthesis 
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'DWDH[WUDFWLRQDQGV\QWKHVLVZHUHFRQGXFWHGEDVHGRQWKHµEHVWILW¶IUDPHZRUN
V\QWKHVLVPHWKRGZKLFKSURYLGHVµDPHDQVWRWHVWUHLQIRUFHDQGEXLOGRQDQH[LVWLQJ
published model, conceived for a potentially differenWEXWUHOHYDQWSRSXODWLRQ¶(Carroll et al., 
2013). Researchers can combine several frameworks if necessary and refine the framework 
by adding new themes that emerged from the data, which are not found in the initial 
framework.  
We first identified a framework on the barriers and facilitators to screening from the 
studies included in this review (Garcia-Dominic et al., 2012), supplemented by two other 
frameworks by Christy et al and Denberg et al, which focused on masculinity (avoidance of 
femininity, self-reliance, risk taking and heterosexual self-presentation) and screening 
procedure respectively, to form a more comprehensive meta-framework (Christy et al., 2014; 
Denberg et al., 2005). This meta-framework was then pilot tested by two researchers against 
ten studies before the final framework was decided.  
Two researchers extracted the data from each included paper and coded them 
deductively using the meta-framework. Data that could not fit the meta-framework were 
coded separately under a new theme in a subsequent inductive phase. Data that were unclear 
or without sufficient explanation were excluded from the analysis. 
Once data from all studies were extracted, the researchers compared the coding, 
discussed and resolved any discrepancy through consensus. The themes from the meta-
framework and the newly generated themes were combined using the thematic approach to 
produce the final framework of barriers and facilitators to health screening in men. The 
analysis including the quotations can be obtained from the researchers upon request. 
 
Additional Analysis 
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Besides aiming to develop the comprehensive framework of barriers and facilitators 
to health screening in men, we also sought to find out which are the most common barriers or 
facilitators by counting the number of studies that reported a barrier or facilitator and ranking 
them accordingly.  
In addition, we sought to identify the barriers and facilitators that are found 
predominantly in men, using to two methods. For qualitative studies (53 qualitative paper 
plus qualitative components of 4 mixed-method papers), criteria for deciding male-dominant 
barriers and facilitators in men appear in Appendix C. For quantitative studies, barriers and 
facilitators were considered male-dominant when there were significantly higher percentage 
of barriers or facilitators reported by men compared to women, with p < .05. 
 
Results 
,QFOXGHG6WXGLHV¶&KDUDFWHULVWLFV 
We identified 14322 articles from five databases, contact with experts and follow up 
of references (excluding duplicates and non-journal articles) (Fig. 1). We eventually included 
103 studies in the review which consisted of 53 qualitative, 44 quantitative and 6 mixed-
method studies. In four out of six mixed-method studies, only the qualitative component of 
the study was included as the quantitative component did not meet our inclusion criteria. In 
the other two mixed-method studies both qualitative and quantitative components of the study 
were included in the analysis. 
[INSERT FIGURE 1 ABOUT HERE] 
The characteristics of all studies and their references are presented in Appendix D. 
The studies were conducted from 1985 to 2012 and in North America (k=62), Europe (k=14), 
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Africa (k=9), Oceania (k=8), Asia (k=6) and South America (k=4). Most of the studies were 
conducted in the community (k=70); few in the healthcare setting (k=19); and a small 
number in both settings (k=3). All included quantitative studies were cross-sectional studies. 
Most qualitative studies (k=53) did not report their study design and the most commonly 
reported study designs were grounded theory (k=3), phenomenology (k=2) and ethnography 
(k=1). More than half of the included studies (k=65) did not report using a theory in their 
study. Of those reported, the Health Belief Model (k=16) was the most commonly used 
theory (Champion VL, 2008). 
Among the included studies, the most commonly studied screening topics were 
prostate cancer (k=40), colorectal cancer (k=33) and HIV (k=15) and the remainder included 
sexually transmitted disease (k=4), cancer (k=4), testicular cancer (k=3), cardiovascular 
disease (k=2), skin cancer (k=1) and multiphasic examination (k=1). Twenty studies were 
conducted as a part of a screening program. Most included both attendees and non-attendees 
of screening (k=73), 11 studies included ever-screened participants; 9 studies included never-
screened participants; while 10 studies did not report.   
Out of 103 studies, 37 reported barriers, 13 facilitators and 55 both barriers and 
facilitators. Only 30 studies focused exclusively on barriers or facilitators to screening while 
VWXGLHVIRFXVHGRQSDUWLFLSDQWV¶DWWLWXGHVEHOLHIs and knowledge of a disease of which 
barrier to screening was only a constituent of the studies. Among the 103 studies, 47 
FRPSDUHGPHQ¶VEDUULHUVDQGIDFLOLWDWRUVWRWKRVHRIZRPHQZKLOHRQO\IRFXVHGRQPHQ¶V
barriers. Of 24 quantitative studies comparing barriers/facilitators between men and women, 
only 13 reported p-values in their studies. 
 
Barriers and Facilitators to Health Screening in Men 
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Factors influencing uptake of health screening in men fall within five domains: 
individual, social, health system, healthcare professional and screening procedure (Table 1). 
The six individual factors that influence health screening uptake in men are knowledge, 
attitudes and values, fear, masculinity attributes, communication and resources. Factors 
within the social domain include influence of family and/or peers as well as stigma. For the 
health system domain, factors include accessibility to screening services, cost and insurance, 
health information, screening program or policy, men's health advocacy and quality of 
service. Healthcare professional factors include attitudes, communication, physician's gender 
and ethnicity as well as physician's recommendation. The nature of the screening procedure 
DOVRDIIHFWVPHQ¶VGHFLVLRQVDVWRZKHWKHURUQRWWRDWWHQGKHDOWh screening. 
[INSERT TABLE 1 ABOUT HERE] 
There are several barriers and facilitators under each factor. The most commonly 
reported barrier to health screening across all domains is fear of being diagnosed with the 
disease and its consequences (k=52) (Table 2), followed by a perception of low risk (k=39) 
and fear of a painful screening procedure (k=37). The most commonly reported facilitators 
are perceived risk (k=31), perceived benefits of screening (k=DQGSK\VLFLDQV¶
recommendations to attend screening (k=24). 
[INSERT TABLE 2 ABOUT HERE] 
Table 3 shows barriers and facilitators to screening found to be dominant in 
heterosexual men based on the 57 qualitative studies. Heterosexual self-presentation (k=18), 
avoidance of femininity (k=18), self-reliance (k=10), seeking help only when disease is 
severe (k=9) and avoidance of illness (k=7) are the most commonly reported male dominant 
barriers to screening. Partner's role (k=18), perceived risk (k=2), wanting to stay healthy to 
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take care of family (k=2), non-invasive screening procedure (k=DQGSK\VLFLDQV¶JHQGHU
(k=2) are the most commonly reported male dominant facilitators to screening. 
[INSERT TABLE 3 ABOUT HERE] 
Table 4 shows barriers and facilitators to screening found to be dominant in men 
based on the 13 quantitative studies. Lack of time (k=6), fear of getting disease and its 
consequences (k=2), painful screening procedure (k=2) and lack of knowledge about disease 
and screening (k=2) are the barriers found to be significantly more common in men compared 
to women. For facilitators, having knowledge about disease and screening (k=1) and 
SK\VLFLDQ¶VUHFRPPHQGDWLRQWRVFUHHQLQJk=1) were found to be more important in men. 
However, unlike qualitative studies, masculinity factors were rarely reported in the 
quantitative studies. 
[INSERT TABLE 4 ABOUT HERE] 
 Among the five domains, the individual domain is the most commonly cited domain 
in the ten most commonly reported barriers (70.0%) as well as in qualitative (60.9%) and 
quantitative studies (62.5%) reporting male-dominant barriers (Table 5). The pattern is less 
obvious for the facilitators to health screening in men.  
[INSERT TABLE 5 ABOUT HERE] 
 
Quality Assessment 
Overall, included studies carried a moderate risk of bias. Most qualitative studies 
satisfied all assessment criteria except for criteria 4, where most studies did not report 
ZKHWKHUWKHUHVHDUFKHUV¶UROHPLJKWLQIOXHQFHWKHRXWFRPHRIWKHVWXG\$SSHQGL[%7KH
quality of quantitative studies was substantially lower as only about half of the studies 
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satisfied criteria 1 (sampling strategy) and criteria 4 (response rate). These patterns were 
almost similar to the included mixed-method studies. The quality of mixed-method 
integration was moderate. 
 
Discussion 
This systematic review is the first to provide a comprehensive coverage of barriers 
and facilitators to health screening in men. The barriers and facilitators extracted in this study 
are those specifically expressed by men and are different from other disease-specific 
systematic reviews, which are often not gender-specific. Masculinity and characteristics of 
the screening procedure are highlighted as two important factors among the list of barriers 
DQGIDFLOLWDWRUVWKDWLQIOXHQFHPHQ¶VGHFLVLRQVLQWDNLQJXSVFUHHQLQJ:HDOVRLGHQWLILHGWKH
most common factors as well as those that are predominant in men. 
7KLVUHYLHZLGHQWLILHGµPDVFXOLQLW\¶DVDQLPSRUWDQWIDFWRUZKLFKLPSHGHVVFUHHQLQJ
in men; this factor is seldom highlighted in the literature as a barrier to screening in men. We 
used a previously published concept of masculinity as part of our analysis framework during 
data extraction (Christy et al., 2014) and masculinity attributes such as self-reliance, 
avoidance of femininity and heterosexual self-presentation emerged as barriers to screening. 
2QO\µLQYLQFLELOLW\EHOLHI¶HPHUJHGDVDQHw barrier under masculinity attributes from the 
VWXGLHV,QWHUHVWLQJO\DQLPSRUWDQWPDVFXOLQLW\DWWULEXWHRQµULVNWDNLQJ¶GLGQRWIHDWXUH
VSHFLILFDOO\DVDEDUULHULQWKHVWXGLHVLQFOXGHGLQWKLVUHYLHZZKLFKFRXOGEHEHFDXVHµULVN
WDNLQJ¶LVDQDWWULEXte that is difficult to probe in an interview when men do not perceive 
themselves to be at risk. We also realized that most papers included in this review only 
discussed masculinity in the context at individual level. Nonetheless, masculinity can be 
structured in institutional practices and policies, which are not explored in this review 
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(Connell, 1987, 1995; Dovel et al., 2015)6RPHRIWKHLQGLYLGXDOIDFWRUVVXFKDVµDYRLGLQJ
DQGGHQ\LQJLOOQHVV¶µVHHNKHOSRQO\ZKHQGLVHDVHLVVHYHUH¶DQGµIHDURIJHWWLQJGLVHDVH¶
could be related to masculinity, but the authors did not explicitly report the link. Future 
studies should explore this issue. 
µ6FUHHQLQJSURFHGXUH¶ZDVDQRWKHUXQLTXHIDFWRUWKDWHPHUJHGIURPRXUUHYLHZ
Though many studies identify screening procedures as a barrier, such as the collection of 
faeces for bowel cancer screening, different procedures impose different levels of reluctance 
for men to present for screening (Lo et al., 2013; Vart, 2010). Procedures that are most 
commonly cited as a barrier are digital rectal examination, colonoscopy and sigmoidoscopy. 
Such procedures, involving anal penetration, have a sexual connotation and heterosexual men 
are concerned that they might be perceived as being gay. Clinicians should emphasize that 
these procedures are recommended for all men and the invasive nature of the procedure is 
necessary to detect tumors in the colon; therefore, men should not perceive the procedures as 
being gay. Unlike other factors, such as individual, social, healthcare system and healthcare 
professional factors, which are non-disease specific, screening procedure is therefore disease-
specific. More work needs to be done to overcome this barrier.  
In the included studies, tKHPRVWFRPPRQO\UHSRUWHGIDFWRULQIOXHQFLQJPHQ¶V
attendance at health screening relates to their knowledge regarding health and screening, 
which LQWXUQDIIHFWVPHQ¶VSHUFHSWLRQRIWKHLURZQKHDOWKULVNDQGWKHEHQHILWVRIVFUHHQLQJ
Some men are fearful of being diagnosed with the disease if they go for screening and, 
therefore, choose not to know about their health status. It is important for healthcare 
providers to assess and provide information on individual health risks as well as to explain 
the benefit and risks of health screening.  
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We also identified several male-dominant barriers and facilitators to health screening 
in men. Masculinity attributes such as heterosexual self-presentation, avoidance of femininity 
and self-reliance are the most commonly cited male-dominant barriers to screening. It is 
important to note that masculinity attributes vary in different contexts. For example, a study 
comparing barriers to colorectal screening between two Hispanics subpopulations, Spanish 
Americans and first-generation Mexicans, in New Mexico, USA found that machismo is 
more prominent in the latter (Getrich et al., 2012). Other barriers, such as lack of time, lack of 
knowledge, fear and screening procedure are also found more predominantly in men. For 
IDFLOLWDWRUVWRVFUHHQLQJNQRZOHGJHSDUWQHU¶VUROHDQGSK\VLFLDQV¶UHFRPPHQGDWLRQDUHWKH
most important factors that motivate men to attend health screening. 
We also found that while individual factors contribute to most barriers to health 
screening in men, it is not as commonly cited as a facilitator. Thus, for a screening 
intervention targeting men to be effective, it may not be enough to just address individual 
barriers; strategies involving external factors, such as family and friends, health system, 
healthcare professional and screening procedure, may need to be incorporated to enhance 
screening uptake. A study by Holland et al has found that combining personalized letter to 
men and a reminder system by the healthcare professional resulted in a higher uptake of 
health screening as compared to sending a personalized letter alone (Holland et al., 2005). 
The uptake is even higher when the intervention was supplemented by asking the partners to 
encourage men to go for health screening. 
Another important point to note is that this systematic review only included studies 
that reported barriers and facilitators to screening from men themselves independent from 
associations with social determinants to screening uptake. Dryden et al reported that those not 
attending health checks were typically from low socio-economic status, less well educated, 
single (not married), smokers, having low self-efficacy and less likely to believe in the 
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efficacy of health checks. In contrast attenders were usually White and older in age (Dryden 
et al., 2012). We did not include these social determinants because this systematic review 
aimed to find out the actual barriers and facilitators to screening in men irrespective of the 
profile of men who would or would not seek help.  
 
Limitations 
This review has several limitations. This review did not include studies focusing on 
men who were gene carriers, prisoners, disabled, drug users, in military service, homeless, 
immigrants, refugees as well as aboriginal and gay men. These groups of men face additional 
barriers when seeking healthcare and deserve separate reviews, some of which have been 
published. For example, systematic reviews have been conducted on barriers to HIV testing 
in men who have sex with men (MSM) (Lorenc et al., 2011) and hepatitis C testing in people 
who inject drugs (Jones et al., 2014).  
We also did not analyze the barriers and facilitators according to age, which may 
influence how men decide to go for screening. Most of these studies included in this 
systematic review were conducted in Western countries, which may reduce their validity in 
the global South. We also identified four potentially relevant non-English articles (2 Japanese; 
1 Korean; 1 Swedish) which we did not include in this review.  
 The quality of the quantitative studies included in this review was generally poor, 
particularly in terms of questionnaire design. The questionnaires were not validated 
rigorously and factor analysis was typically not performed. Some included options represent 
compound questions (e.g., µFRVWO\ODFNRILQVXUDQFH¶VRPHUHVSRQVHVZHUHQRWPHDQLQJIXO
(e.g., µ,GRQRWNQRZ¶DQGµ,MXVWGRQRWZDQWWR¶8QOLNHWKHILQGLQJVIURPTXDOLWDWLYHVWXGLHV
the barriers and facilitators reported in quantitative studies lack depth and hence were less 
 18 
XVHIXOIRUWKHXQGHUVWDQGLQJRIWKHIDFWRUVWKDWLQIOXHQFHPHQ¶VGHFLVLRQWRDWWHQGVFUHHQLQJ
:HRQO\UHSRUWHGµFRPPRQO\UHSRUWHGEDUULHUV¶UDWKHUWKDQµWKHPRVWFRPPRQEDUULHUV¶GXH
to the heterogeneity of study methods. Some studies permitted participants to choose multiple 
barriers while others only allowed them to choose the single most important barrier. 
Masculinity-related factors are less commonly reported because it is both difficult to ask men 
about this and, in turn, for them to admit such issues. Many studies did not incorporate 
masculinity attributes in the design of the questionnaire. Additionally, only 13 out of 24 
studies that compared men and women reported a p-value. Further evidence is required to 
support the male-dominant barriers or facilitators based on p-values, such as reported in this 
review. We also did not exclude lower quality studies based on the MMAT in order to elicit 
the widest possible range of barriers and facilitators.  
 
Conclusion 
This systematic review identified individual, social, health system, healthcare 
professional and screening procedure factors as important barriers and facilitators to health 
screening in men. In addition, it expands existing framework on factors influencing health 
screening uptake in men, incorporating male-dominant barriers and facilitators such as 
avoidance of femininity, heterosexual self-SUHVHQWDWLRQDQGSDUWQHU¶VUROHLQWRWKHIUDPHZRUN
The findings from this review also provide a better understanding of men¶VVFUHHQLQJ
behaviour; they highlight the importance of considering the role of gender when advising 
men on health screening and when developing health policy on health prevention. The 
development of interventions to promote health screening should take into consideration the 
gender-specific barriers and facilitators identified in this review.  
 
 19 
Conflict of Interest:  
The authors declare that there is no conflict of interest. 
  
Appendices: 
Appendix A. Search strategy 
Appendix B. Quality appraisal result (MMAT) 
Appendix C. Male dominant criteria  
Appendix D. Characteristics of included studies 
 
  
 20 
References 
Addis, M.E., & Mahalik, J.R. (2003). Men, masculinity, and the contexts of help seeking. Am. 
Psychol., 58(1), 5-14. 
AIHW (2013). The health of Australia's males: 25 years and over. Available from: 
http://www.health.gov.au/internet/main/publishing.nsf/Content/male-policy. [Last 
accessed: Apr, 2015] 
Baker, P., Dworkin, S.L., Tong, S., Banks, I., Shande, T., & Yameyf, G. (7KHPHQ¶V
health gap: men must be included in the global health equity agenda. Bull. World 
Health Organ., 92, 618±620. 
Banks, I. (2004). New models for providing men with health care. J. Mens Health, 1(2-3), 
155-158. 
Barford, A., Dorling, D., Davey Smith, G., & Shaw, M. (2006). Life expectancy: women now 
on top everywhere. BMJ, 332(7545), 808. 
Barton, P., Andronis, L., Briggs, A., McPherson, K., & Capewell, S. (2011). Effectiveness 
and cost effectiveness of cardiovascular disease prevention in whole populations: 
modelling study. BMJ, 343, d4044. 
Bilsker, D., Goldenberg, L., & Davison, J. (2010). A Roadmap to Men's Health: Current 
Status, Research, Policy & Practice. Vancouver: Men's Health Initiative of British 
Columbia. 
Borkhoff, C.M., Saskin, R., Rabeneck, L., Baxter, N.N., Liu, Y., Tinmouth, J., et al. (2013). 
Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in 
Ontario, Canada: a population-based study using area-based methods. Can. J. Public 
Health, 104(4), e284-290. 
Byrnes, J.P., Miller, D.C., & Schafer, W.D. (1999). Gender differences in risk taking: A 
meta-analysis. Psychol. Bull., 125(3), 367. 
Carroll, C., Booth, A., Leaviss, J., & Rick, J. (2013). "Best fit" framework synthesis: refining 
the method. BMC Med. Res. Methodol., 13, 37. 
Champion VL, S.C. (2008). The health belief model. In B.K. Glanz K, Viswanath K. (Ed.), 
Health behaviour and health education: theory, research and practice. (pp. 45±5250). 
San Francisco: Jossey-Bass. 
Christy, S.M., Mosher, C.E., & Rawl, S.M. (2014). Integrating men's health and masculinity 
theories to explain colorectal cancer screening behavior. Am. J. Mens Health, 8(1), 
54-65. 
 21 
Connell, R. (1987). Gender and Power: Society, the Person and Sexual Politics. Sydney: 
Allen & Unwin; Cambridge, Polity Press; Stanford, Stanford University Press. 
Connell, R. (1995). Masculinities. Cambridge: Polity Press; Sydney, Allen & Unwin; 
Berkeley, University of California Press. 
Courtenay, W. (2003). Key determinants of the health and well-being of men and boys. Int. J. 
0HQ¶V+HDOWK, 2(1), e30. 
Denberg, T.D., Melhado, T.V., Coombes, J.M., Beaty, B.L., Berman, K., Byers, T.E., et al. 
(2005). Predictors of nonadherence to screening colonoscopy. J. Gen. Intern. Med., 
20(11), 989-995. 
Dovel, K., Yeatman, S., Watkins, S., & Poulin, M. (2015). Men's heightened risk of AIDS-
related death: the legacy of gendered HIV testing and treatment strategies. AIDS, 
29(10), 1123-1125. 
Dryden, R., Williams, B., McCowan, C., & Themessl-Huber, M. (2012). What do we know 
about who does and does not attend general health checks? Findings from a narrative 
scoping review. BMC Public Health, 12(1), 723. 
EC (2011). The State of Men's Health in Europe: Extended Report. Available from: 
http://ec.europa.eu/health/population_groups/docs/men_health_extended_en.pdf [Last 
accessed: Apr, 2015] 
Garcia-Dominic, O., Lengerich, E.J., Wray, L.A., Parrott, R., Aumiller, B., Kluhsman, B., et 
al. (2012). Barriers to CRC Screening Among Latino Adults in Pennsylvania: ACCN 
Results. Am. J. Health Behav., 36(2), 153-167. 
Getrich, C.M., Sussman, A.L., Helitzer, D.L., Hoffman, R.M., Warner, T.D., Sanchez, V., et 
al. (2012). Expressions of machismo in colorectal cancer screening among New 
Mexico Hispanic subpopulations. Qual. Health Res., 22(4), 546-559. 
Hewitson, P., Glasziou, P., Irwig, L., Towler, B., & Watson, E. (2007). Screening for 
colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database 
Syst. Rev.(1), Cd001216. 
Holland, D.J., Bradley, D.W., & Khoury, J.M. (2005). Sending men the message about 
preventive care: An evaluation of communication strategies. Int. J. Mens Health, 4(2), 
97-114. 
Jones, L., Atkinson, A., Bates, G., McCoy, E., Porcellato, L., Beynon, C., et al. (2014). 
Views and experiences of hepatitis C testing and diagnosis among people who inject 
drugs: systematic review of qualitative research. Int. J. Drug Policy, 25(2), 204-211. 
 22 
Lee, H., Cho, J., Shin, D.W., Lee, S.P., Hwang, S.S., Oh, J., et al. (2015). Association of 
cardiovascular health screening with mortality, clinical outcomes, and health care cost: 
a nationwide cohort study. Prev. Med., 70, 19-25. 
Lo, S.H., Halloran, S., Snowball, J., Seaman, H., Wardle, J., & von Wagner, C. (2015). 
Colorectal cancer screening uptake over three biennial invitation rounds in the 
English bowel cancer screening programme. Gut, 64(2), 282-291. 
Lo, S.H., Waller, J., Wardle, J., & von Wagner, C. (2013). Comparing barriers to colorectal 
cancer screening with barriers to breast and cervical screening: a population-based 
survey of screening-age women in Great Britain. J. Med. Screen., 20(2), 73-79. 
Lorenc, T., Marrero-Guillamon, I., Llewellyn, A., Aggleton, P., Cooper, C., Lehmann, A., et 
al. (2011). HIV testing among men who have sex with men (MSM): Systematic 
review of qualitative evidence. Health Educ. Res., 26(5), 834-846. 
Ng, C.J., Teo, C.H., Ho, C.C., Tan, W.P., & Tan, H.M. (2014). The status of men's health in 
Asia. Prev. Med., 67C, 295-302. 
Pace, R., Pluye, P., Bartlett, G., Macaulay, A.C., Salsberg, J., Jagosh, J., et al. (2012). Testing 
the reliability and efficiency of the pilot Mixed Methods Appraisal Tool (MMAT) for 
systematic mixed studies review. Int. J. Nurs. Stud., 49(1), 47-53. 
3OX\H35REHUW(&DUJR0%DUWOHWW*2¶&DWKDLQ$*ULIILWKV)HWDO
Proposal: A mixed methods appraisal tool for systematic mixed studies reviews. 
Available from: http://mixedmethodsappraisaltoolpublic.pbworks.com. Archived by 
WebCite® at http://www.webcitation.org/5tTRTc9yJ. [Last accessed: Jan, 2015] 
Tappenden, P., Eggington, S., Nixon, R., Chilcott, J., Sakai, H., & Karnon, J. (2004). 
Colorectal cancer screening options appraisal: Cost-effectiveness, cost-utility and 
resource impact of alternative screening options for colorectal cancer. Report to the 
English Bowel Cancer Screening Working Group. Sheffield: ScHARR. 
United States Preventive Services Task Force (2016). USPSTF A and B Recommendations. 
Available from: http://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-
and-b-recommendations/. [Last accessed: Mar, 2016] 
Vart, G.F. ( 2010). How men differ from women in their attitudes towards bowel cancer 
screening and intention to be screened. J. Mens Health, 7, 241-248. 
Weller, D.P., & Campbell, C. (2009). Uptake in cancer screening programmes: a priority in 
cancer control. Br. J. Cancer, 101 Suppl 2, S55-59. 
White, A., De Sousa, B., De Visser, R., Hogston, R., Madsen, S.A., Makara, P., et al. (2011a). 
Men's health in Europe. J. Mens Health, 8(3), 192-201. 
 23 
White, A., McKee, M., Richardson, N., Visser, R., Madsen, S.A., Sousa, B.C., et al. (2011b). 
Europe's men need their own health strategy. BMJ, 343, d7397. 
WHO (2001 ). Madrid Statement Mainstreaming gender equity in health: the need to move 
forward. Available from: 
http://www.euro.who.int/__data/assets/pdf_file/0008/76508/A75328.pdf [Last 
accessed: Apr, 2015] 
WHO (2011). Life expectancy: Life expectancy by WHO region. Available from: 
http://apps.who.int/gho/data/view.main.690?lang=en. [Last accessed: Nov 2014] 
 
 24 
Table 1. Barriers and facilitators to health screening in men synthesized from all studies.   
INDIVIDUAL DOMAIN 
FACTORS Barriers Facilitators 
Knowledge x Low risk perception (lack of symptom, no family 
history) 
x Perceived at risk (having symptoms, having family 
history, being old and following a risky event) 
x Lack of knowledge about disease and screening x Having knowledge about disease and screening 
x Feeling inferior/fear of attending screening due to 
limited education and literacy 
 
Attitudes and 
values 
o Avoiding and denying illness  
o Fatalism belief o Religious belief that a man should take care of his 
body 
o Negative attitude (lazy, procrastination or forgot) o Positive attitude (health conscious, screening as a 
routine and care for others) 
o Sceptical of the benefits of screening o Perceived benefits of screening (early intervention 
and peace of mind) 
o Seek help only when disease is severe  
o Health is not a priority o Stay healthy to take care of family 
o Not trusting the doctor or health system o Trusting the doctor or health system 
o Having other health concerns  
o Already tested or diagnosed o Already tested or diagnosed 
o Belief that illness can be healed naturally or with 
CAM 
 
Emotion - Fear  )HDURIJHWWLQJGLVHDVHDQGFRQVHTXHQFHDQGGRQ¶W
want to know 
 Fear of disease and consequence and want to find 
out earlier 
Masculinity ¾ Avoidance of femininity - seeking help or talking 
about health is considered feminine or weak 
 
¾ Heterosexual self-presentation - Undergoing DRE ¾ Heterosexual self-presentation - Use other 
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or colonoscopy may be perceived as gay screening method rather than DRE 
¾ Self-reliance - do not want to depend on doctors ¾ To feel in control 
¾ Invincibility belief ¾ Non-existence of machismo attributes 
Communication × Discomfort discussing issues regarding private 
part and disease 
 
× Language barrier  
Resource 9 Lack of time  
9 Lack of income and personal insurance 9 Having personal insurance 
9 Lack of personal transport 9 Having personal transportation 
SOCIAL DOMAIN 
FACTORS Barriers Facilitators 
Family and peer 
influence 
x Lack of encouragement x Encouragement and support from siblings, 
children, relative, friends and other social contact 
x Past negative health care experience x Partner's role 
x No social contact with the disease x Knowing someone with disease or died due to the 
disease 
Stigma o Concern about being stigmatized  
HEALTH SYSTEM DOMAIN 
FACTORS Barriers Facilitators 
Accessibility to 
screening services 
x Inconvenient opening hour, day and location x Convenient screening location, hour and day 
x Difficulty in making appointment x Screening without appointment required 
x Long waiting time x Short waiting time 
x Busy HCP  
Cost and insurance o Costly services o Free/reduced cost exams  
o Lack of insurance o Having insurance coverage 
Health information  Lack of public education  More public education programs through media, 
community, school and health centre 
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 Inaccurate and negative information  Church as a platform to promote health screening 
  Celebrity-led campaign and advertisement 
Screening 
programme or 
policy 
 ¾ Availability of screening program or policy 
(workplace, marriage) 
Men's health 
advocacy 
× Lack of men's health advocacy   
Quality of service 9 Male-unfriendly healthcare setting 9 Reminder by health provider 
9 Lack of confidentiality 9 Confidentiality 
9 Negative experience in health centre 9 Opportunistic screening 
9 Limited access to treatment 9 Availability of treatment 
 9 Trained HCP 
HEALTHCARE PROFESSIONAL DOMAIN 
FACTORS Barriers Facilitators 
Attitude x Negative attitude (rude, discrimination and 
uncaring) 
 
Communication x Lack of rapport with doctor x Having good rapport with doctor 
x Lack of bilingual physicians x Availability of bilingual healthcare professional 
 x Shared decision making 
Physician's gender 
and ethnicity 
o Availability of physician of the same ethnicity o Preference of female physicians to perform DRE 
Physician's 
recommendation 
 Lack of physician recommendation for screening 
tests 
 Recommended to screening 
SCREENING PROCEDURE DOMAIN 
FACTORS Barriers Facilitators 
The nature of 
screening 
x Painful and uncomfortable  x Less painful and discomfort procedure 
x Embarrassing procedure  
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CAM=Complementary alternative medicine. DRE=Digital Rectal Examination. HCP=Healthcare Professional. 
procedure x Complication following procedure 
 x Lack of privacy  
x Difficult procedure preparation  x Convenience test procedure 
x Difficult sample collection  
x Impersonal procedure  
x Screening package lack comprehensiveness 
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Table 2. Ten most commonly reported barriers and facilitators to health screening in men 
from all studies. 
Barriers 
No. of 
citing 
studies 
(k=92) 
Facilitators 
No. of 
citing 
studies 
(k=68) 
Fear of getting disease and 
consequence (I) 
52 Perceived at risk - having 
symptoms, having family 
history, being old and following 
a risky event (I) 
31 
Low risk perception -  lack of 
symptom, no family history (I) 
39 Perceived benefits of screening - 
early intervention and peace of 
mind (I) 
29 
Painful and uncomfortable 
screening procedure (SP) 
37 3K\VLFLDQ¶VUHFRPPHQGDWLRQWR
screening (HCP) 
24 
Lack of time (I) 33 Partner's role (S) 22 
Lack of knowledge about disease 
and screening (I) 
30 More public education program 
through media, community, 
school and health centre (HS) 
18 
Embarrassing screening procedure 
(SP) 
29 Positive attitude - health 
conscious, screening as a routine 
and care for others (I) 
16 
Costly screening services (HS) 23 Knowing someone with disease or 
died due to the disease (S) 
15 
Seeking help or talking about 
health is considered feminine 
or weak (I) 
21 Encouragement and support from 
siblings, children, relative, 
friends and other social contact 
(S) 
12 
Undergoing DRE or colonoscopy 
may be perceived as gay (I) 
20 Availability of screening program 
or policy -  workplace, marriage 
(HS) 
11 
Avoiding and denying illness (I) 20 Having knowledge about disease 
and screening (I) 
11 
DRE=Digital Rectal Examination. HCP=Healthcare Professional. HS=Health System. 
I=Individual. S=Social. SP=Screening Procedure.
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Table 3. Barriers and facilitators to screening found to be dominant in men based on 57 qualitative studies. 
FACTORS 
Number 
of studies 
Barriers  
Heterosexual self-presentation - Undergoing DRE6 or colonoscopy may be 
perceived as gay (I) 
18 
Avoidance of femininity - seeking help or talking about health is considered 
feminine or weak (I) 
18 
Self-reliance - do not want to depend on doctors (I) 10 
Seek help only when disease is severe (I) 9 
Avoiding and denying illness (I)  7 
Invincibility belief (I) 6 
Embarrassing screening procedure (SP) 5 
Health is not a priority (I) 4 
Fear of getting disease and consequence (I) 4 
Lack of encouragement (S) 3 
Male-unfriendly healthcare setting (HS) 3 
Lack of privacy (SP) 3 
Lack of knowledge about disease and screening (I) 3 
Fatalism belief (I) 3 
Lack of Men's Health Advocacy (HS) 2 
Negative attitude - lazy, procrastination or forgot (I) 2 
Lack of public education (HS) 2 
Not trusting the doctor or health system (I) 2 
Low risk perception - lack of symptom, no family history (I) 2 
Difficult sample collection (SP) 1 
Complication following procedure (SP) 1 
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Lack of time (I) 1 
Concern about being stigmatized (S) 1 
  
Facilitators   
Partner's role (S) 18 
Heterosexual self-presentation - Use other screening method rather than DRE6 
(SP) 
2 
Preference of female physicians to perform DRE6 (HCP) 2 
Stay healthy to take care of family (I) 2 
Perceived at risk - Having symptoms, having family history, being old and 
following a risky event (I) 
2 
Inexistence of machismo attributes (I) 1 
To feel in control (I)  1 
Opportunistic screening (HS)  1 
Convenience test procedure (SP)  1 
More public education programs through media, community, school and health 
center (HS)  
1 
Recommended to attend screening (HCP)  1 
DRE=Digital Rectal Examination. HCP=Healthcare Professional. HS=Health System. I=Individual. S=Social. SP=Screening Procedure. 
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Table 4. Barriers and facilitators to screening which are either more dominant in men (Sig-male), no significant difference (ns), or more 
dominant in women (Sig-female) based on p-value reported in 13 quantitative papers. 
FACTORS Sig-
male ns 
Sig-
female 
Barriers    
Lack of time (I) 6 1 0 
Fear of getting disease and consequence (I) 2 5 2 
Painful and uncomfortable (SP) 2 2 1 
Lack of knowledge about disease and screening (I) 2 1 0 
Low risk perception - lack of symptom, no family history (I) 1 4 1 
Embarrassing procedure (SP) 1 1 3 
Complication following procedure (SP) 1 1 1 
Skeptical of the benefits of screening (I) 1 1 0 
Costly services (HS) 0 5 0 
Difficult procedure preparation (SP) 0 2 1 
Negative attitude - lazy, procrastination or forgot (I) 0 2 0 
Lack of personal transport (I) 0 2 0 
Concern about being stigmatized (S) 0 2 0 
Inconvenient opening hour, day and location (HS) 0 2 0 
Having other health concerns (I) 0 1 1 
Already tested or diagnosed (I) 0 1 1 
/DFNRISK\VLFLDQ¶VUHFRPPHQGDWLRQ+&3 0 1 1 
Avoiding and denying illness (I) 0 1 0 
Health is not a priority (I) 0 1 0 
Lack of income and personal insurance (I) 0 1 0 
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Past negative health care experience (HS) 0 1 0 
Difficulty in making appointment (HS) 0 1 0 
Lack of confidentiality (HS) 0 1 0 
HCP¶VQHJDWLYHDWWLWXGH+&3 0 1 0 
Difficult sample collection (SP) 0 1 0 
Lack of encouragement (S) 0 0 1 
 
 
 
 
Facilitators    
Having knowledge about disease and screening (I) 1 0 0 
Recommended to screening (HCP) 1 0 0 
Perceived at risk - Having symptoms, having family history, being old 
and following a risky event (I) 0 2 1 
Availability of screening program or policy - workplace, marriage (HS) 0 2 0 
Perceived benefits of screening - early intervention and peace of mind 
(I) 0 1 0 
Partner's role (S)  0 1 0 
Positive attitude - Health conscious, screening as a routine and care for 
others (I) 0 0 1 
Physician of the same gender (HCP) 0 0 1 
HCP=Healthcare Professional. HS=Health System. I=Individual. S=Social. SP=Screening Procedure. 
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Table 5. Summary of the ten most commonly reported and male-dominant (qualitative and quantitative study) barriers and facilitators 
to screening in men according to domain. 
DOMAIN Barriers  k (%) 
Facilitators 
k (%) 
Ten most commonly reported factors 10 (100%) 10 (100%) 
Individual (I) 7 (70.0%) 4 (40.0%) 
Social (S) 0 (0%) 3 (30.0%) 
Health system (HS) 1 (10.0%) 2 (20.0%) 
Healthcare professional (HCP) 0 (0%) 1 (10.0%) 
Screening procedure (SP) 2 (20.0%) 0 (0%) 
   
Male-dominant - qualitative study 23 (100%) 11 (100%) 
Individual (I) 14 (60.9%) 4 (36.4%) 
Social (S) 2 (8.7%) 1 (9.1%) 
Health system (HS) 3 (13.0%) 2 (18.2%) 
Healthcare professional (HCP) 0 (0%) 2 (18.2%) 
Screening procedure (SP) 4 (17.4%) 2 (18.2%) 
 
  
Male-dominant - quantitative study 8 (100%) 2 (100%) 
Individual (I) 5 (62.5%) 1 (50.0%) 
Social (S) 0 (0%) 0 (0%) 
Health system (HS) 0 (0%) 0 (0%) 
Healthcare professional (HCP) 0 (0%) 1 (50.0%) 
Screening procedure (SP) 3 (37.5%) 0 (0%) 
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Appendix A. Search strategy 
PubMed (k=5906) 
NO. SEARCH STRATEGY 
#5 (#1 AND #2 AND #3 AND #4) 
#4 (Qualitative Research[mh] OR Interviews as topic[Mh] OR Questionnaires[Mh] OR 
EƵƌƐŝŶŐŵĞƚŚŽĚŽůŽŐǇƌĞƐĞĂƌĐŚ ?ŵŚ ?KZYƵĂůŝƚĂƚŝǀĞ ?ƚŝĂď ?KZ “&ŽĐƵƐŐƌŽƵƉ ? ? ?ƚŝĂď ?
OR Interview*[tiab] OR Survey*[tiab]) 
#3 (facilitat*[tiab] OR encourag*[tiab] OR promot*[tiab] OR motivat*[tiab] OR 
enabl*[tiab] OR Predict*[tiab] OR Support*[tiab] OR barrier*[tiab] OR 
obstacle*[tiab] OR difficult*[tiab] OR imped*[tiab] OR reluctan*[tiab] OR 
refus*[tiab] OR Counteract*[tiab] OR Challeng*[tiab] OR Utiliz*[tiab] OR Utilis*[tiab] 
OR Uptake*[tiab] OR Decision making[mh] OR patient acceptance of health 
care[mh] OR attitude to health[mh]) 
#2 (Early diagnosis[mh] OR mass screening[mh] OR preventive health 
ƐĞƌǀŝĐĞƐ ?ŵŚ ?ŶŽĞǆƉ ?KZ^ĐƌĞĞŶ ? ?ƚŝĂď ?KZ “,ĞĂůƚŚĐŚĞĐŬ ? ? ?ƚŝĂď ?KZĐŚĞĐŬƵƉ ? ?ƚŝĂď ?
OR check-up*[tiab] OR ((routine[tiab] OR regular[tiab] OR yearly[tiab] OR 
ĂŶŶƵĂů ?ƚŝĂď ?KZƉĞƌŝŽĚŝĐ ?ƚŝĂď ? ?E ? ?ŚĞĂůƚŚĞǆĂŵŝŶĂƚŝŽŶ ? ? Ăď KZ “ŵĞĚŝĐĂů
ĞǆĂŵŝŶĂƚŝŽŶ ? ?ƚŝĂď ?KZ “ŚĞĂůƚŚĂƐƐĞƐƐŵĞŶƚ ? ?ƚŝĂď ? ? ? ? 
#1 (Male[tiab] OR Man[tiab] OR Males[tiab] OR Men[tiab] OR Boy[tiab] OR Boys[tiab] 
OR Gender*[tiab] OR Prostat*[tiab]) 
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EMBASE (k =8399) 
NO. SEARCH STRATEGY 
#5 #1 AND #2 AND #3 AND #4 
#4 
 
'qualitative research'/exp OR qualitative:ab,ti OR 'interview'/exp OR 
'questionnaire'/exp OR 'nursing methodology research'/exp OR 'focus group':ab,ti OR 
'focus groups':ab,ti OR interview*:ab,ti OR survey*:ab,ti 
#3 
 
facilitat*:ab,ti OR encourag*:ab,ti OR promot*:ab,ti OR motivat*:ab,ti OR 
enabl*:ab,ti OR predict*:ab,ti OR support*:ab,ti OR barrier*:ab,ti OR obstacle*:ab,ti 
OR difficult*:ab,ti OR imped*:ab,ti OR reluctan*:ab,ti OR refus*:ab,ti OR 
counteract*:ab,ti OR challeng*:ab,ti OR utiliz*:ab,ti OR utilis*:ab,ti OR uptake*:ab,ti 
OR 'decision making'/exp OR 'patient attitude'/exp OR 'attitude to health'/exp 
#2 
 
male:ab,ti OR man:ab,ti OR males:ab,ti OR men:ab,ti OR boy:ab,ti OR boys:ab,ti OR 
gender*:ab,ti OR prostat*:ab,ti 
#1 
 
'early diagnosis'/exp OR 'mass screening'/de OR 'anonymous testing'/de OR 'auditory 
screening'/de OR 'cancer screening'/de OR 'genetic screening'/de OR 'preventive 
health services'/de OR screen*:ab,ti OR 'health check':ab,ti OR 'health checks':ab,ti 
OR checkup*:ab,ti OR 'check up':ab,ti OR 'check ups':ab,ti OR (routine:ab,ti OR 
regular:ab,ti OR yearly:ab,ti OR annual:ab,ti OR periodic:ab,ti AND ('health 
examination':ab,ti OR 'medical examination':ab,ti OR 'health assessment':ab,ti)) 
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CINAHL via EBSCOHOST (k =2513) 
NO. SEARCH STRATEGY 
#5 (#1 AND #2 AND #3 AND #4)  
#4 (MH  “YƵĂůŝƚĂƚŝǀĞ ZĞƐĞĂƌĐŚ ?A? ? OR (MH "Interviews+") OR (MH "Focus Groups") OR 
(MH "Questionnaires+") OR TI (Qualitative OR  “&ŽĐƵƐ ŐƌŽƵƉ ? ? OR Interview* OR 
Survey*) OR AB (Qualitative OR  “&ŽĐƵƐ ŐƌŽƵƉ ? ? OR Interview* OR Survey*)  
#3 TI (facilitat* OR encourag* OR promot* OR motivat* OR enabl* OR Predict* OR 
Support* OR barrier* OR obstacle* OR difficult* OR imped* OR reluctan* OR refus* 
OR Counteract* OR Utiliz* OR Utilis* OR Uptake*) OR AB (facilitat* OR encourag* OR 
promot* OR motivat* OR enabl* OR Predict* OR Support* OR barrier* OR obstacle* 
OR difficult* OR imped* OR reluctan* OR refus* OR Counteract* OR challeng* OR 
Utiliz* OR Utilis* OR Uptake*) OR (MH "Decision Making, Patient") OR (MH "Decision 
Making") OR (MH "Decision Support Techniques") OR (MH "Attitude to Health") OR 
(MH "Health Beliefs") OR (MH "Attitude to Risk") OR (MH "Attitude to Life") OR (MH 
"Patient Attitudes") 
#2 TI (Male OR Man OR Males OR Men OR Boy OR Boys OR Gender* OR Prostat*) OR 
AB (Male OR Man OR Males OR Men OR Boy OR Boys OR Gender* OR Prostat*) OR 
(MH "Gender Bias")  
#1 (MH "Health Screening+") OR (MH "Early Diagnosis+") OR (MH "Preventive Health 
Care") OR TI (Screen* OR  “,ĞĂůƚŚ ĐŚĞĐŬ ? ? OR Checkup* OR check-up* OR ((routine 
OR regular OR yearly OR annual OR periodic) AND  ? ‘ŚĞĂůƚŚ ĞǆĂŵŝŶĂƚŝŽŶ ? OR  ‘ŵĞĚŝĐĂů 
ĞǆĂŵŝŶĂƚŝŽŶ ? OR  ‘ŚĞĂůƚŚ ĂƐƐĞƐƐŵĞŶƚ ? ? ? ? OR AB (Screen* OR  “,ĞĂůƚŚ ĐŚĞĐŬ ? ? OR 
Checkup* OR check-up* OR ((routine OR regular OR yearly OR annual OR periodic) 
AND  ? ‘ŚĞalth ĞǆĂŵŝŶĂƚŝŽŶ ? OR  ‘ŵĞĚŝĐĂů ĞǆĂŵŝŶĂƚŝŽŶ ? OR  ‘ŚĞĂůƚŚ ĂƐƐĞƐƐŵĞŶƚ ? ? ? ?  
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PscyInfo via OvidSP (k =1942) 
NO. SEARCH STRATEGY 
#5 (#1 and #2 and #3 and #4) 
#4 exp Qualitative Research/ or exp Questionnaires/ or Interviews/ or Qualitative.ti,ab. or 
'Focus group*'.ti,ab. or Interview*.ti,ab. or Survey*.ti,ab. 
#3 (facilitat* or encourag* or promot* or motivat* or enabl* or Predict* or Support* or 
barrier* or obstacle* or difficult* or imped* or reluctan* or refus* or Counteract* or 
challeng* or Utiliz* or Utilis* or Uptake*).ti,ab. or exp Decision making/ or exp health 
attitude/ or health behaviour/ 
#2 (Male or Man or Males or Men or Boy or Boys or Gender* or Prostat*).ti,ab. or Human 
sex differences/ 
#1 exp health screening/ or preventive medicine/ or Screen*.ti,ab. or 'Health check'.ti,ab. or 
'Health checks'.ti,ab. or Checkup*.ti,ab. or check-up*.ti,ab. or ((routine or regular or 
yearly or annual or periodic) and ('health examination' or 'health examinations' or 
'medical examination' or 'medical examinations' or 'health assessment' or 'health 
assessments')).ti,ab. 
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Web of Science (k =6730) 
NO SEARCH STRATEGY 
# 5 #4 AND #3 AND #2 AND #1 
# 4 TOPIC:  ?YƵĂůŝƚĂƚŝǀĞKZ “ĨŽĐƵƐŐƌŽƵƉ ? ?KZ “ŝŶƚĞƌǀŝĞǁ ? ?KZYƵĞƐƚŝŽŶŶĂŝƌĞ ?KZ
Survey*) 
# 3 TOPIC: (facilitat* OR encourag* OR promot* OR motivat* OR enabl* OR Predict* OR 
Support* OR barrier* OR obstacle* OR difficult* OR imped* OR reluctan* OR refus* 
KZŽƵŶƚĞƌĂĐƚ ?KZŚĂůůĞŶŐ ?KZhƚŝůŝǌ ?KZhƚŝůŝƐ ?KZhƉƚĂŬĞ ?KZ “ĞĐŝƐŝŽŶ
ŵĂŬŝŶŐ ?KZƚƚŝƚƵĚĞ ?KZĐĐĞƉƚ ? ? 
# 2 TOPIC: (Male OR Man OR Males OR Men OR Boy OR Boys OR Gender* OR Prostat*) 
# 1 TOPIC:  ? “ĂƌůǇĚŝĂŐŶŽƐŝƐ ?KZ “ĂƌůǇĚĞƚĞĐƚŝŽŶ ?KZ^ĐƌĞĞŶ ?KZ “,ĞĂůƚŚĐŚĞĐŬ ? ?KZ
checkup* OR check-ƵƉ ?KZ “ƉƌĞǀĞŶƚŝǀĞŚĞĂůƚŚ ?KZ ? ?ƌŽƵƚŝŶĞKZƌĞŐƵůĂƌKZǇĞĂƌůǇ
OR annual OR periŽĚŝĐ ?E ? ?ŚĞĂůƚŚĞǆĂŵŝŶĂƚŝŽŶ ?KZ “ŵĞĚŝĐĂůĞǆĂŵŝŶĂƚŝŽŶ ?KZ
 “ŚĞĂůƚŚĂƐƐĞƐƐŵĞŶƚ ? ? ? ? 
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Appendix B. Criteria for male-dominant barriers and facilitators in qualitative studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ĞŐ ? “ĞĐĂƵƐĞŵĞŶĂƌĞ
lacking of knowledge about 
ĚŝƐĞĂƐĞĂŶĚƐĐƌĞĞŶŝŶŐ ? ? 
Does the data make implicit comparison 
to women or generalisation to men? 
ĞŐ ? “ĞĐĂƵƐĞŵĞŶŚĂǀĞůĞƐƐ
knowledge about disease and 
ƐĐƌĞĞŶŝŶŐĐŽŵƉĂƌĞĚƚŽǁŽŵĞŶ ? 
Male-
dominant 
Is the data compared to women and 
occurred predominantly in men? 
ĞŐ ? “&ĞĂƌŽĨƚĞƐƚƌĞƐƵůƚ ? ? 
 “ŵďĂƌƌĂƐƐŵĞŶƚŝŶƉƌŽĐĞĚƵƌĞ ? ? 
 “>ĂĐŬŽĨŚĞĂůƚŚŬŶŽǁůĞĚŐĞ ? 
Not using the word  
 “ŵĞŶ ?ĂŶĚŶŽƚŽŶĞŽĨ
generalisation to men. 
ĞŐ ? “ĞĐĂƵƐĞI do not 
know much about disease 
ĂŶĚƐĐƌĞĞŶŝŶŐ ? ? ?DĂŶ ? ? ? ? 
ĞŐ ? “DĞŶŚĂǀĞůŽǁůĞǀĞůŽĨhealth knowledge and this 
ŝŵƉĞĚĞƐƚŚĞŵĨƌŽŵĂƚƚĞŶĚŝŶŐŚĞĂůƚŚƐĐƌĞĞŶŝŶŐ ? ? 
ĞŐ ? “DĞŶŚĂǀĞůŽǁůĞǀĞůŽĨ
health knowledge.  
Is this factor linked to getting screened? 
Check evidence in:  
x the sentence itself 
x the start of the paragraph 
x the question asked before this answer 
x the subheading of the cited text 
x the objective 
x the methods 
No 
Not male-
dominant 
No Exclude 
ĞŐ ? “DĞŶĂŶĚƚŚĞŝƌŵĂƐĐƵůŝŶŝƚǇ ? ? 
  “,ŽŵŽƐĞǆƵĂůĐŽŶŶŽƚĂƚŝŽŶ ? ?
 “tŝĨĞ ?ƐƐƵƉƉŽƌƚ ? 
Does it apply to women? Is there a 
ĐŚĂŶĐĞĨŽƌƚŚŝƐďĂƌƌŝĞƌƚŽďĞĂ ‘ŐĞŶĞƌĂů ?
barrier?  
Yes 
Male-
dominant 
Male -
dominant 
hƐŝŶŐƚŚĞǁŽƌĚ “ŵĞŶ ?ĂŶĚƚŚĞƚŽŶĞ 
of the sentence is generalising to men. 
ĞŐ ? “DĞŶĚŽŶŽƚŐŽĨŽƌƐĐƌĞĞŶŝŶŐ
because they do not know much about 
ĚŝƐĞĂƐĞĂŶĚƐĐƌĞĞŶŝŶŐ ? ? 
No 
No 
Yes 
Yes 
Yes 
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Appendix C. Results of quality assessment using MMAT. 
Criteria 
QL 
k=53 
QN 
k=44 
MM 
k=6 
QL.1. Are the sources of qualitative data (archives, 
documents, informants, observations) relevant to address 
the research question (objective)? 
Yes 89%  67% 
No 2%  0% 
Can't tell 9%  33% 
QL.2. Is the process for analyzing qualitative data relevant 
to address the research question (objective)? 
Yes 92%  50% 
No 2%  33% 
Can't tell 6%  17% 
QL.3. Is appropriate consideration given to how findings 
relate to the context, e.g., the setting, in which the data 
were collected? 
Yes 100%  100% 
No 0%  0% 
Can't tell 0%  0% 
QL.4. Is appropriate consideration given to how findings 
ƌĞůĂƚĞƚŽƌĞƐĞĂƌĐŚĞƌƐ ?ŝŶĨůƵĞŶĐĞ ?Ğ ?Ő ? ?ƚŚƌŽƵŐŚƚŚĞŝƌ
interactions with participants? 
Yes 8%  0% 
No 83%  100% 
Can't tell 9%  0% 
QN.1. Is the sampling strategy relevant to address the 
quantitative research question (quantitative aspect of the 
mixed methods question)? 
Yes  61% 83% 
No  9% 17% 
Can't tell  30% 0% 
QN.2. Is the sample representative of the population 
understudy? 
Yes  91% 83% 
No  0% 0% 
Can't tell  9% 17% 
QN.3. Are measurements appropriate (clear origin, or 
validity known, or standard instrument)? 
Yes  98% 100% 
No  0% 0% 
Can't tell  2% 0% 
QN.4. Is there an acceptable response rate (60% or 
above)? 
Yes  41% 50% 
No  23% 33% 
Can't tell  36% 17% 
M.1. Is the mixed methods research design relevant to 
address the qualitative and quantitative research 
questions (or objectives), or the qualitative and 
quantitative aspects of the mixed methods 
question/objective? 
Yes   83% 
No   17% 
Can't tell   0% 
M.2. Is the integration of qualitative and quantitative data 
(or results*) relevant to address the research question 
(objective)? 
Yes   50% 
No   17% 
Can't tell   33% 
M.3. Is appropriate consideration given to the limitations 
associated with this integration, e.g., the divergence of 
qualitative and quantitative data (or results*) in a 
triangulation design? 
Yes   33% 
No   17% 
Can't tell   50% 
*Type of study: QL=Qualitative; QN=Quantitative; MM=Mixed-method 
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Appendix D. Summary of the characteristics of studies included in this review. 
CHARATERISTICS No. of studies (k=103) 
Type of study  
x Qualitative 53 
x Quantitative 44 
x Mixed-method 6 
 
 
Gender focus 
 x Focusing on men's barriers only 56 
x Comparing men's and women's barriers 47 
 
 
Barrier/facilitator or broad focus 
 x Main focus on barrier 30 
x Broad focus (knowledge, attitude, belief) 73 
 
 
Outcome reported (barrier or facilitator) 
 x Barrier only 37 
x Facilitator only 13 
x Both 55 
 
 
Study design 
 x Cross-sectional 44 
x Grounded theory 3 
x Phenomenology 2 
x Ethnography 1 
x Not reported (qualitative) 53 
  
Range of study dates 1985-2012 
 
 
Country 
 x North America (USA & Canada) 62 
x Europe (UK, Germany, Spain, Sweden, Denmark, France & Israel) 14 
x Africa (Uganda, Nigeria, South Africa, Burkina Faso and Ethiopia) 9 
x Oceania (Australia & New Zealand) 8 
x Asia (Japan, China, Hong Kong, Singapore & Taiwan) 6 
x South & Central America (Brazil, Jamaica, Trinidad and Tobago) 4 
 
 
Setting 
 x Healthcare setting 19 
x Community 70 
x Both 3 
x Not reported  11 
 
 
Disease 
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x Prostate cancer 40 
x Colorectal cancer 33 
x HIV 15 
x Sexually transmitted diseases 4 
x Cancer (in general) 4 
x Testicular Cancer 3 
x Cardiovascular disease 2 
x Skin cancer 1 
x Multiphasic examination 1 
 
 
Screening programme involved 
 x Yes 20 
x No 83 
 
 
Age range 14-98 years 
  
Screening status 
 x Ever 11 
x Never 9 
x Both 73 
x Not reported 10 
 
 
Sampling strategy 
 x Convenience 36 
x Purposive 31 
x Random 17 
x Universal 6 
x Not reported 6 
x Systematic 5 
x Consecutive 2 
 
 
Data collection method 
 x Self-completion questionnaire 15 
x Interviewer-assisted  18 
x Telephone interview 6 
x Postal questionnaire 7 
x Focus group discussion 31 
x In-depth interview 24 
x Focus group discussion and In-depth interview 4 
 
 
Theories used 
 x Not Reported 65 
x Health belief model 16 
x No theory used (grounded theory) 5 
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x Theory of planned behaviour 1 
x Theory of reasoned action 1 
x Transtheoretical model 1 
x Social marketing 1 
x ŶĚĞƌƐĞŶ ?ƐĞŚĂǀŝŽƌDŽĚĞůŽĨ,ĞĂůƚŚ^ĞƌǀŝĐĞƐhƐĞ 1 
x Preventive Health Model 1 
x Social-cognitive models, health action process approach 1 
x Health Belief Model and Social Determinants of Health 1 
x Culture Care Diversity and Universality theory 1 
x Precaution Adoption Process Model 1 
x Masculinity and health theory (Courtenay) 1 
x Predisposing, Reinforcing, and Enabling Constructs in 
Educational/Environmental Diagnosis and Evaluation (PRECEDE) 
model 
1 
x Cues to action 1 
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Characteristics of included qualitative studies (k=53) 
First author 
and year 
Disease for 
screening 
Country 
and setting 
Year of 
study 
Gender 
focus 
Sampling 
and sample 
size 
Ethnicity,  
age and 
screening status  
Theory used Data 
collection 
method 
Data 
analysis 
Austin 2009 Colorectal 
Cancer 
UK 
NR 
Feb 2007 
 W July 2008 
Comparison Convenience 
20 men 
33 women 
Minorities 
50 - 78 
NR 
Health belief 
model 
FGD Framework 
and thematic 
Bass 2011 Colorectal 
Cancer 
USA 
Healthcare 
setting 
Sep 2007 
 W Feb 2008 
Comparison Purposive 
8 men 
25 women 
African American 
50 - 64 
Both 
NR FGD Thematic 
Blocker 2006 Prostate 
Cancer 
USA 
Community 
Fall 2002 
 W winter 
2003 
Male-specific Convenience 
14 men 
15 women 
African American 
34 - 68 
Both 
Health Belief 
Model 
FGD Thematic 
Carter 2008 Prostate 
Cancer 
USA 
Community 
NR Male-specific NR 
35 men 
39 women 
African American 
>40 
Both 
NR FGD Thematic 
Chaudhary 
2010 
Chlamydia UK 
Community 
NR Male-specific Purposive 
15 men 
Various 
19-24 
Both 
NR FGD Thematic 
Christianson 
2008 
HIV Sweden 
Healthcare 
setting 
NR Comparison Convenience 
9 men 
14 women 
Various 
18-24 
Ever-screened 
NR FGD Thematic 
Conde 2011 Prostate 
Cancer 
USA 
Community 
NR Male-specific Purposive 
20 men 
Filipino 
above 40 
Both 
NR FGD Thematic 
Dale 1999 Prostate 
Cancer 
USA 
Community 
NR Male-specific Convenience 
96 men 
African American 
and White 
39 to 95 
Both 
Health belief 
model 
FGD Framework 
and textual 
Elwood 1975 Multiphasic 
examinatio
n 
USA 
NR 
NR Male-specific Systematic 
25 men 
White 
53-62 
Never-screened 
NR IDI NR 
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Evans 2007 Prostate 
Cancer 
UK 
Community 
NR Male-specific Purposive 
28 men 
White 
40 to 75 
Both 
NR IDI Constant 
comparison 
and thematic 
Fernandez 
2008 
Colorectal 
Cancer 
USA 
Community 
NR Comparison Purposive 
33 men 
55 women 
5 female lay 
health 
worker 
Latino 
50 to 91 
Both 
NR FGD Thematic 
Ferrante 
2011 
Prostate 
Cancer 
USA 
Community 
Mar 2009 
 W May 
2010 
Male-specific Purposive 
64 men 
Various 
50 and above 
Both 
ŶĚĞƌƐĞŶ ?Ɛ
Behavior 
Model of 
Health 
Services Use 
IDI Grounded 
Ford 2006 Prostate 
Cancer 
USA 
Community 
NR Male-specific Random 
21 men 
African American 
55 and above 
Both 
Preventive 
Health 
Model 
FGD Content and 
thematic 
Forrester-
Anderson 
2005 
Prostate 
Cancer 
USA 
Community 
NR Male-specific Convenience 
104 men 
African American 
40 to 80 
Both 
Grounded 
theory 
FGD Thematic 
Friedemann-
Sanchez 
2007 
Colorectal 
Cancer 
USA 
Healthcare 
setting 
Sep 2004 
 W Dec 2004 
Comparison Purposive 
43 men 
27 women 
Various 
50 to 75 
Both 
Grounded 
and 
interpretive 
FGD Grounded 
and 
interpretive 
Garcia-
dominic 
2012 
Colorectal 
Cancer 
USA 
NR 
Apr 2009 
 W May 
2009 
Comparison Convenience 
40 men 
42 women 
Latino 
26-77 
Both 
Health belief 
model 
FGD Thematic 
Gesink 2014 Colorectal 
Cancer 
Canada 
NR 
Jun 2011 
 W May 
2012 
Comparison Convenience 
33 men 
88 women 
19 HCP 
Various 
20 and above for 
HCP, 30 and 
above for laymen 
Both 
Grounded 
theory 
IDI and 
FGD 
Grounded 
Getrich 2012 Colorectal 
Cancer 
USA 
Healthcare 
Aug 2008 
 W Jul 2009 
Comparison Purposive 
26 men 
Hispanic 
50 and above 
NR IDI Thematic 
and Iterative 
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setting 26 women 
14 HCP 
Both analytic 
process 
Hannover 
2010 
Prostate 
Cancer 
Germany 
Healthcare 
setting 
NR Male-specific Convenience 
83 men 
Various 
45 above 
Both 
Social-
cognitive 
models, 
health action 
process 
approach 
IDI Content 
Harris 1998 Colorectal 
Cancer 
Australia 
NR 
NR Comparison Random 
12 men 
12 women 
Various 
40 to 70 
Ever-screened 
NR FGD Thematic 
Harvey 2011 Prostate 
Cancer 
USA 
Community 
NR Male-specific Convenience 
15 men 
African American 
40 and above 
Both 
Preventive 
health model 
FGD Thematic 
Hunter 2007 Cardiovasc
ular 
USA 
NR 
May 2002 
 W Apr 2003 
Male-specific Convenience 
29 men 
83 women 
25 HCP 
Mexican 
American 
40 and above 
NR 
NR IDI Content and 
thematic 
Ilic 2005 Prostate 
Cancer 
Australia 
NR 
NR Male-specific Purposive 
67 men 
Various 
45 above 
Both 
Grounded 
theory 
FGD Thematic 
James 2013 Colorectal 
Cancer 
USA 
Community 
2006 
 W 2008 
Male-specific Convenience 
29 men 
American Indian 
50 or older 
Both 
NR FGD Thematic 
Jernigan 
2001 
Cancer USA 
NR 
Mar 1998 
 W May 
1998 
Comparison Convenience 
26 men 
19 women 
African American 
50 or older 
Both 
NR FGD NR 
Jones RA 
2009 
Prostate 
Cancer 
USA 
Community 
NR Male-specific Convenience 
17 men 
African American 
40 to 71 
Both 
NR IDI Thematic 
Jones RA 
2010 
Prostate 
Cancer 
USA 
Community 
NR Male-specific Convenience 
17 men 
African American 
40 to 71 
Both 
NR IDI Thematic 
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Larsson 2010 HIV Uganda 
Community 
Apr 2008 
 W Apr 2009 
Male-specific Convenience 
103 men 
Various 
NR 
Both 
NR IDI and 
FGD 
Thematic 
Lasser 2008 Colorectal 
Cancer 
USA 
Community 
Jan 2005 
 W Dec 2006 
Comparison Convenience 
9 men 
14 women 
10 HCP 
Various 
52-74 
Both 
NR IDI Coding and 
constant 
comparison 
Lupton 1995 HIV Australia 
Community 
Mar 1993 
 W Aug 1993 
Comparison Purposive 
50 men and 
women 
Various 
below and above 
30 
Ever-screened 
NR IDI Thematic 
MacCaffery 
2001 
Colorectal 
Cancer 
UK 
Community 
NR Comparison Purposive 
30 men 
30 women 
Various 
55-64 
Never-screened 
Not using IDI Thematic 
Madjar 2007 Prostate 
Cancer 
Australia 
Community 
Oct 2004 
 W Mar 2005 
Male-specific Purposive 
38 healthy 
men 
7 healthy 
women 
18 Pca men 
9 spouse 
Various 
18 to 80 
Both 
NR IDI and 
FGD 
Thematic 
Molina-
Barcelo 2011 
Colorectal 
Cancer 
Spain 
Community 
Mar 
 W Apr 2009 
Comparison Purposive 
24 men 
32 women 
Various 
50 to 69 
Both 
Health Belief 
Model and 
Social 
Determinant
s of Health. 
FGD Thematic 
Ocho 2013 Prostate 
Cancer 
Trinidad 
and Tobago 
Community 
Aug 2011 
 W Jan 2012 
Male-specific Purposive 
75 men 
Various 
19 to 60 
Both 
NR FGD Thematic 
Odedina 
2004 
Prostate 
Cancer 
USA 
Community 
Oct 2001 
 W Mar 2002 
Male-specific Purposive 
49 men 
African American 
40 and above 
Both 
Not using - 
Mentioned 
many but did 
not apply in 
FGD Ethnographic
al 
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method 
Oliver 2007 Prostate 
Cancer 
USA 
Community 
NR Male-specific Convenience 
9 men 
African American 
43 to 72 
Both 
NR IDI Content and 
thematic 
Palmer 2008 Colorectal 
Cancer 
USA 
Community 
Aug 2005 
 W Mar 2006 
Comparison Convenience 
18 men 
18 women 
African American 
50 - 76 
Both 
Predisposing, 
Reinforcing, 
and Enabling 
Constructs in 
Educational/
Environment
al Diagnosis 
and 
Evaluation 
(PRECEDE) 
model 
IDI Thematic 
Patinkin 
2007 
HIV Israel 
Community 
Aug 2003 
 W Oct 2003 
Male-specific Purposive 
10 men 
Various 
24 to 60 
Ever-screened 
NR IDI Content and 
thematic 
Pinnock 
1998 
Prostate 
Cancer 
Australia 
Community 
NR Male-specific Purposive 
134 men 
14 women 
Various 
NR 
NR 
Health Belief 
Model 
FGD analysed 
according to 
HBM 
Plowden 
2006 
Prostate 
Cancer 
USA 
Community 
NR Male-specific Purposive 
12 men 
24 sig 
other/wives/
HCP/child of 
men at risk 
African American 
Men 40 to 79 
others 30 to 72 
Both 
Culture Care 
Diversity and 
Universality 
theory 
IDI Constant 
comparative 
and thematic 
Puaina 2008 Cancer USA 
Community 
NR Male-specific Purposive 
60 men 
Samoan 
50 and above 
NR 
NR FGD Content and 
thematic 
Rai 2007 Prostate 
Cancer 
UK 
Community 
2005 Male-specific Purposive 
20 men 
White 
45 to 75 
Ever-screened 
NR IDI Thematic 
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Reeder 2011 Colorectal 
Cancer 
New 
Zealand 
Community 
NR Comparison Convenience 
20 men 
30 women 
White 
50 to 71 
NR 
NR IDI Content 
Ritvo 2013 Colorectal 
Cancer 
Canada 
Community 
NR Comparison Random 
32 men 
49 women 
Various 
50 to 84 
Never-screened 
Precaution 
Adoption 
Process 
Model 
IDI Constant 
comparison, 
grounded 
and thematic 
Robinson 
1996 
Prostate 
Cancer 
USA 
NR 
Dec 1993 
 W Feb 1994 
Male-specific Purposive 
56 men 
African American 
40 and above 
Both 
NR FGD NR 
Salas-Lopez 
2007 
Cancer USA 
Community 
NR Comparison Convenience 
9 medical 
residents 
Various 
mean = 29.6 
NR 
NR FGD Constant 
comparison 
Sanchez 
2007 
Prostate 
Cancer 
USA 
Community 
Dec 2004 
 W Apr 2005 
Male-specific Convenience 
31 men 
African American 
40 to 70 
Both 
NR FGD Thematic 
Singleton 
2008 
Testicular 
Cancer 
Australia 
Community 
NR Male-specific Purposive 
12 men 
Various 
18 to 23 
Both 
Social 
constructioni
st of 
masculinity 
FGD Thematic 
Thompson 
2012 
Colorectal 
Cancer 
New 
Zealand 
Community 
NR Comparison Convenience 
27 men 
53 women 
Various 
40 to 70 
Both 
Men and 
masculinity 
IDI Thematic 
Wackerbarth 
2005 
Colorectal 
Cancer 
USA 
Community 
NR Comparison Purposive 
13 men 
17 women 
Various 
48 to 55 
Both 
Health belief 
model 
IDI Thematic 
Wackerbarth 
2008 
Colorectal 
Cancer 
USA 
Community 
NR Comparison Purposive 
13 men 
17 women 
Various 
48-60 
Both 
<Ƶƌƚ>ĞǁŝŶ ?Ɛ
theory of 
decision 
making 
IDI Constant 
comparative 
Webb 2006 Prostate 
Cancer 
USA 
Healthcare 
setting and 
NR Male-specific Convenience 
18 men 
14 women 
African American 
40-70 
Both 
NR FGD Thematic 
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community 
Winterich 
2009 
Prostate 
and 
colorectal 
cancer 
USA 
Community 
NR Male-specific Purposive 
64 men 
African American 
and White 
40 to 64 
Both 
Masculinity 
and health 
theory 
IDI Framework 
and thematic 
Note:  
NR = Not reported 
Screening status = Ever-screened or never-screened or both 
Characteristics of included quantitative studies (k=44) 
First author 
and year 
Disease for 
screening 
Country 
and setting 
Study year Gender 
focus 
Sampling 
and sample 
size 
Ethnicity, 
age and 
screening 
status 
Theory 
used 
Data 
collection 
method 
Respons
e rate 
P-value 
reported 
Ashford 2001 Prostate 
Cancer 
USA 
Healthcare 
setting and 
community 
Feb 1995  
 W Jun 1996 
Male-specific Universal 
723 men 
African 
American 
50 - 74  
Both 
Health 
Belief 
Model 
Interview 
assisted 
survey 
95% 
clinic, 
65% 
commu
nity 
No 
Baseman 
2001 
Syphillis USA 
Community 
NR Comparison Purposive 
446 men  
245 women 
Various 
>18  
Both 
NR Interview 
assisted 
survey 
NR No 
Bergenmar 
1997 
Melanoma Sweden 
Community 
1994 Comparison Universal 
61 men  
66 women 
Various 
40 - 60  
Both 
Health 
Belief 
Model 
Telephone 
interview 
63% No 
Biadglegne 
2011 
HIV Ethiopia 
Healthcare 
setting 
Aug 2008  
 W Oct  2008 
Comparison Systematic 
91 men 
131 women 
Various 
18 - 70  
Both 
NR Interview 
assisted 
survey 
NR Yes 
Blanchard 
2005 
Prostate 
Cancer 
USA 
NR 
NR Male-specific Convenience 
324 women 
Various 
>18  
NR 
NR Self-
completion 
questionnaire 
>90% No 
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Blesch 1986 Testicular 
Cancer 
USA 
Community 
NR Male-specific Random 
128 men 
Various 
20 - 60  
Both 
Health 
Belief 
Model 
Self-
completion 
questionnaire 
55% No 
Bloom 2006 Prostate 
Cancer 
USA 
Community 
NR Male-specific Convenience 
208 men 
African 
American 
40 - 74  
Both 
Health 
Belief 
Model 
Interview 
assisted 
survey 
50% No 
Bourne 2010 Prostate 
Cancer 
Jamaica 
Healthcare 
setting 
Feb 2008  
 W Mar 2008 
Male-specific Random 
170 men 
Various 
>29  
Both 
NR Interview 
assisted 
survey 
76.8% No 
Calazel-
Benque 2011 
Colorectal 
Cancer 
France 
Community 
Jan 2005  
 W Feb 2005, 
Dec 2007  
 W Jan 2008  
Comparison NR 
270 men  
305 women 
Various 
40 - 75  
Both 
NR Telephone 
interview 
NA Yes 
Cormier 
2003 
Prostate 
Cancer 
USA 
Community 
1995-2000 Male-specific Convenience 
138 men 
Various 
42 - 93  
Both 
NR Postal 
questionnaire 
89% No 
Cunningham 
2009 
Sexual 
transmitted 
disease 
USA 
Community 
Apr 2004  
 W Apr 2007 
Comparison Random 
230 men  
364 women 
Various 
15 - 24  
Both 
NR Interview 
assisted 
survey 
51% No 
Day 2003 HIV South 
Africa 
Healthcare 
setting 
Jul 2001 Male-specific Systematic 
105 men 
Various 
24 - 61  
Both 
NR Interview 
assisted 
survey 
95% No 
Demark-
Wahnefried 
1995 
Prostate 
Cancer 
USA 
Healthcare 
setting 
1992 Male-specific NR 
1504 men 
African 
American 
and 
White 
Median: 
64  
Ever-
screened 
NR Self-
completion 
questionnaire 
NR No 
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Elnicki 1995 Cardiovasc
ular 
USA 
Healthcare 
setting 
1991 Comparison Consecutive 
75 men  
113 women  
Various 
18 - 88  
Both 
NR Interview 
assisted 
survey 
100% Yes 
Farraye 2004 Colorectal 
Cancer 
USA 
Healthcare 
setting 
NR Comparison Purposive 
241 men  
300 women 
Various 
50 - 89  
Both 
NR Postal 
questionnaire 
56% Yes 
Foldspang 
1990 
HIV Denmark 
Community 
Oct 1998  
 W Dec 1988 
Male-specific Random 
230 men 
Danish 
20 - 49  
Both 
NR Postal 
questionnaire 
77% No 
Green 2004 Colorectal 
Cancer 
USA 
Community 
NR Comparison Convenience 
42 men  
58 women 
African 
American 
50 - 90  
Both 
Health 
Belief 
Model 
Self-
completion 
questionnaire 
NR No 
Iyaniwura 
2006 
HIV Nigeria 
Community 
Apr 2004  
 W May 2004 
Comparison Purposive 
196 men  
197 women 
Various 
15 - 29  
Both 
NR Interview 
assisted 
survey 
NR No 
Katz 1995 Testicular 
Cancer 
USA 
Community 
1993  
 W 1994  
Male-specific Convenience 
78 men 
Various 
mean =23 
Both 
NR Self-
completion 
questionnaire 
NR No 
Larson 2005 Cancer USA 
Community 
Dec 2001  
 WJul 2002 
Comparison Random 
140 men  
360 women 
Various 
DĞŶA? ? ? 
Women 
A?40  
NR 
NR Telephone 
interview 
72% No 
Li 1998 Colorectal 
Cancer 
Japan 
Community 
1991  
 W 1996  
Comparison Universal 
182 men  
174 women 
Various 
40 - 79  
Never-
screened 
NR Postal 
questionnaire 
81% Yes 
Lin 2011 Prostate 
Cancer 
Taiwan 
Community 
Jun 2009  
 W Jan 2010 
Male-specific NR 
330 men 
Various 
38 - 82  
Both 
NR Self-
completion 
questionnaire 
NR No 
McCoy 1995 Prostate 
Cancer 
USA 
Community 
2 weeks 
over 
Male-specific Random 
897 men 
African 
American, 
NR Telephone 
interview 
NR No 
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summer 
1990 
White 
and 
Hispanic 
>65  
Both 
McDougall 
2004 
Prostate 
Cancer 
USA 
Healthcare 
setting 
NR Male-specific Convenience 
19 men 
African 
American 
45 - 76  
Ever-
screened 
NR Self-
completion 
questionnaire 
NR No 
Mugisha 
2010 
HIV Uganda 
Community 
2007 Comparison Random 
66 men  
61 women 
Various 
16 - 44  
Both 
NR Interview 
assisted 
survey 
NR No 
Naik 2012 HIV South 
Africa 
Community 
Sep 2009  
 W Jan 2011 
Comparison Systematic 
560 men  
111 women 
Various 
14 - 98  
Never-
screened 
NR Interview 
assisted 
survey 
99% Yes 
Neale 1989 Colorectal 
Cancer 
USA 
Community 
1985 Male-specific Universal 
128 men 
White 
mean =41  
Never-
screened 
NR Telephone 
interview 
68% No 
Obermeyer 
2009 
HIV Burkina 
Faso 
Healthcare 
setting 
Jan 2006  
 W Feb 2006 
Comparison Convenience 
63 men  
236 women 
Various 
mean =34  
Both 
NR Interview 
assisted 
survey 
100% No 
Oliver 2011 Prostate 
Cancer 
USA 
Community 
May 2007  
 W Aug 2007 
Male-specific Convenience 
94 men 
African 
American 
and 
White 
>40  
Both 
Health 
Belief 
Model 
Self-
completion 
questionnaire 
100% No 
Paiva 2011 Prostate 
Cancer 
Brazil 
Community 
NR Male-specific Random 
160 men 
African 
American, 
NR Self-
completion 
NR No 
 54 
White 
and 
Mestizo 
50 - 80  
Both 
questionnaire 
Parchment 
2004 
Prostate 
Cancer 
USA 
Community 
NR Male-specific Convenience 
100 men 
African 
American 
and 
Caribbean 
men 
37 - 89  
Both 
The 
Theory 
of 
Reasone
d Action 
Self-
completion 
questionnaire 
Low No 
Rafael 2012 Prostate 
Cancer 
Brazil 
Healthcare 
setting 
Jun 2011 Male-specific Random 
101 men 
Various 
40 - 59  
Both 
NR Interview 
assisted 
survey 
NR No 
Raich 1997 Prostate 
Cancer 
USA 
Community 
1994 Male-specific Universal 
436 men 
Various 
Not clear  
Ever-
screened 
NR Postal 
questionnaire 
64% No 
Ramos 2011 Colorectal 
Cancer 
Spain 
Healthcare 
setting 
Jan 2009  
 W Jun 2009 
Comparison Systematic 
261 men  
361 women 
Various 
50 - 69  
Both 
NR Self-
completion 
questionnaire 
95% No 
Sanders 
2007 
Sexual 
transmitted 
disease 
USA 
Community 
2004  
 W 2005  
Comparison NR 
50 men  
106 women 
Various 
14 - 20  
Never-
screened 
Health 
Belief 
Model 
Self-
completion 
questionnaire 
40.6% No 
Shelton 1999 Prostate 
Cancer 
USA 
Community 
NR Male-specific Purposive 
1395 men 
African 
American 
40 - 70  
Both 
Theory 
of 
Planned 
Behavio
r  
Self-
completion 
questionnaire 
NR No 
Tobin-west 
2014 
HIV Nigeria 
Community 
May 2011  
 W Jun 2011 
Comparison Random 
267 men  
Various 
>15  
NR Interview 
assisted 
NR Yes 
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368 women Both survey 
Vernon 1990 Colorectal 
Cancer 
USA 
Community 
Spring 1988 Male-specific Purposive 
113 men 
Various 
NR  
Both 
NR Telephone 
interview 
80.7% No 
Vincent 2011 Colorectal 
Cancer 
USA 
Community 
Jan 2009  
 W Feb 2009 
Comparison Random 
542 men  
689 women 
Various 
50 - 80  
Both 
Transth
eoretica
l Model 
Postal 
questionnaire 
30.85% Yes 
Watanabe 
2004 
HIV Japan 
Healthcare 
setting 
Apr 2001  
 W Mar 2002 
Comparison Universal 
2515 men  
1587 women 
Various 
19 - 70  
Ever-
screened 
NR Self-
completion 
questionnaire 
56.6% No 
Wong MC 
2013 
Colorectal 
Cancer 
Hong Kong 
Healthcare 
setting 
May 2008  
 W Sep 2012 
Comparison Consecutive 
4384 men  
5689 women 
Various 
50 - 70  
Never-
screened 
Health 
Belief 
Model 
Self-
completion 
questionnaire 
NR Yes 
Wong RK 
2013 
Colorectal 
Cancer 
Singapore 
Community 
2007  
 W 2008  
Comparison Random 
693 men  
1050 women 
Various 
>50  
Both 
Health 
Belief 
Model 
Interview 
assisted 
survey 
88.2% Yes 
Zhou 2009 HIV China 
Healthcare 
setting 
Jul 2006  
 W Jun 2007  
Comparison NR 
1957 men  
719 women 
Various 
20 - 65  
Ever-
screened 
NR Interview 
assisted 
survey 
35.6% Yes 
Zimmerman 
1997 
Prostate 
Cancer 
USA 
Healthcare 
setting 
1995 Male-specific Convenience 
51 men 
Hispanic 
35 - 78  
Ever-
screened 
Social 
Marketi
ng 
Interview 
assisted 
survey 
100% No 
Note:  
NR = Not reported 
Screening status = Ever-screened or never-screened or both 
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Characteristics of included mixed-method studies (k=6) 
First 
author 
and year 
Disease 
for 
screening 
Country Setting Study year Gender 
focus 
Sampling 
and sample 
Ethnicity, age 
and screening 
status 
Theory 
used 
Data 
collection 
method 
Data Analysis 
Bastani 
2001 (QL) 
Colorectal 
Cancer 
USA NR Sep 1998  
 W Dec 1998 
Compari
son 
Purposive 
23 men  
28 women 
Various 
>50 
NR 
NR FGD   Thematic 
Bwambale 
2008 (QL) 
HIV Uganda 
Healthcare 
setting 
Jan 2005  
 W Apr 2005 
Male-
specific 
Purposive 
40 men  
10 women 
Various 
>18  
Both 
NR 
FGD and IDI Thematic 
Bwambale 
2008 (QN) 
Community Random 
780 men 
Various 
18 - 90 
Both 
Interview 
assisted 
survey 
Response rate: 
NR 
P-value: No 
Denberg 
2005 (QL) 
Colorectal 
Cancer 
USA Community Mar 2004  
 W Apr 2004 
Compari
son 
Convenience 
25 men  
27 women 
Various 
>50  
Never-screened 
Ground
ed 
theory 
IDI Thematic 
 
Jones RM 
2010 (QL) 
Colorectal 
Cancer 
USA Community 
Dec 2005  
 W Jun 2006 
Compari
son 
Convenience 
15 men  
25 women 
Various 
45 - 75 
Both 
NR 
FGD   Thematic 
Jones RM 
2010 (QN) 
Jun 2005  
 WJul 2005 
Random 
103 men  
201 women 
Various 
50 - 75 
Both 
Postal 
questionnaire 
Response rate: 
48% 
P-value: Yes 
Katz 2004 
(QL) 
Colorectal 
Cancer 
USA Community 1998 Compari
son 
Convenience 
3 grps men  
3 grps 
women 
African 
American 
>50 
NR 
NR FGD NR 
Matterne 
2008 (QL) 
Colorectal 
Cancer 
Germany Community NR Male-
specific 
Convenience 
71 men 
Various 
45 - 70 
Both 
Cues to 
Action  
IDI Thematic 
Note:  
NR = Not reported 
Screening status = Ever-screened or never-screened or both 
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Fig. 1. PRISMA Flow Diagram. 
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